TESARO 8-K Highlights Initiation Of Second Stage Of Its JASPER Trial Of ZEJULA In Combo With TSR-042 In Non-Small Cell Lung Cancer; Reports All Evaluable Patients Experienced Tumor Shrinkage
luke@benzinga.com